| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |